Creating a synthetic kidney to address the shortage of transplantable organs
The Synthetic Kidney: A Revolutionary Solution for the Shortage of Kidneys for Transplantation
This study is exploring a new way to create a synthetic kidney using special cells, which could be grown inside patients with end-stage kidney disease to offer them a better treatment option than traditional transplants.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-10473323 on NIH RePORTER |
What this research studies
This research focuses on developing a synthetic kidney that can be engineered from native progenitor cells, mimicking the structure and function of an embryonic kidney. The synthetic kidney will be transplanted into the abdomen of patients, where it will grow and mature, potentially providing a viable alternative to traditional kidney transplants. The approach aims to overcome the current limitations in kidney replacement therapies by utilizing innovative bioengineering techniques. Patients with end-stage renal disease will be the primary focus, as they face limited options for treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are suffering from end-stage renal disease and are in need of a kidney transplant.
Not a fit: Patients with acute kidney injury or those who do not have chronic kidney disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the availability of functional kidneys for transplantation, improving survival rates and quality of life for patients with kidney failure.
How similar studies have performed: While the concept of a synthetic kidney is innovative, similar bioengineering approaches have shown promise in other organ replacement therapies, indicating potential for success in this area.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Li, Zhongwei — University of Southern California
- Study coordinator: Li, Zhongwei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.